CLINICAL_TRIALS
trial_result
· 2019-07-26
Clinical Trial Update: Dose Finding Study of BI 6727 (Volasertib) in Patients With Various Solid Cancers [Phase 1]
Summary
Phase 1 dose-finding study of volasertib (BI 6727) in patients with various solid cancers completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Neoplasms | Phase 1 | Status: COMPLETED | Results posted: 2019-07-26